Are 'Microwave-Safe' Containers Actually Safe? Experts Break It Down
Microwave ovens are the unsung heroes of our kitchens. Whether it is reheating last night's butter chicken or steaming a quick bowl of noodles, they have rescued us from many hunger emergencies, even in the middle of the night. And what do we usually toss into the microwave without a second thought? That trusty plastic container with the 'microwave-safe' label slapped on it. But here is the question: Are these containers actually safe for microwave use?
It turns out, 'microwave-safe' plastic is not always as safe as it sounds. Surprised? No need to panic yet, we are here to break it down clearly.
Also Read: Is It Safe To Heat Food In Microwave? Expert Reveals
What Does 'Microwave-Safe' Mean For Plastic Containers?
Our kitchens are overflowing with plastic containers proudly flaunting the 'microwave-safe' label. But how many of us have paused to wonder what that label really means? Most of us have not.
Health educator Dr Pulkit Kumar sheds some light on this. According to him, the term simply means that the container will not melt or warp when exposed to microwave heat. That is it. It does not guarantee that the plastic will not release harmful chemicals into your food.
In fact, Dr Kumar emphasises that this label is often misunderstood. "People assume it means the plastic is completely safe for food contact under heat, but that is not necessarily true. It just means the container can survive the microwave, not that your food will survive the chemicals," he explains.
Also Read: 5 Important Tips To Use Microwave Safely
Health Risks Of Microwaving Food In Plastic Containers:
Most plastic containers may look harmless, but they often contain two sneaky chemicals: phthalates and bisphenol A (BPA), which help maintain their shape and flexibility. But these chemicals are anything but harmless when exposed to heat.
Clinical nutritionist Rupali Datta explains that both BPA and phthalates are classified as endocrine disruptors. That means they can interfere with the body's hormone system, particularly oestrogen and testosterone. These hormones play a crucial role in reproductive health, and any disruption can lead to serious consequences, especially for children. In fact, the Paediatric Environmental Health Speciality Unit (PEHSU) in the United States has highlighted that these chemicals can affect growth, development, and reproductive function in children.
Rupali Datta further points out that the World Health Organisation (WHO) has also raised concerns. According to WHO, microwaving food in plastic containers increases the risk of these chemicals leaching into your food, especially when the food is hot, oily, or acidic.
Also Read: Microwave Do's And Don'ts: What Not To Put Inside
Is BPA-Free Plastic Safe For Microwaving Food?
Absolutely not. According to the Citizen Consumer and Civic Action Group (CAG), many plastic food containers marketed as BPA-free and food-grade still pose serious health risks. This is because manufacturers often replace BPA with other chemicals like bisphenol S (BPS) or bisphenol F (BPF), which are equally harmful.
These BPA alternatives can also leach into your food when heated, particularly in a microwave oven. Moreover, CAG stresses that BPA-free plastics can still contain phthalates - another group of endocrine-disrupting chemicals that mess with your hormones. So, while the label might sound reassuring, the reality is far from it: 'BPA-free' does not mean 'chemical-free'. It just means BPA has been swapped for its equally shady alternative.
Is Food-Grade Silicone Safe To Use In The Microwave?
If you are looking for a safer alternative to plastic in the microwave, food-grade silicone might just be your best bet. Approved by the U.S. Food and Drug Administration (FDA) for use in food contact applications, silicone is known for being durable, flexible, and heat-resistant. Unlike plastic, it does not warp or release harmful chemicals when exposed to microwave heat if it is used within recommended temperature limits. That makes it a practical and modern upgrade for your everyday kitchen needs.
What Are The Best Containers For Microwave Use?
Consultant nutritionist Rupali Datta shares that when it comes to microwaving food safely, glass or ceramic containers are the gold standard. They are sturdy, non-reactive, and do not leach chemicals into your food.
But remember, not all glass or ceramic dishware is microwave safe. Some may have metallic trims, glazes, or materials that can crack or spark under heat. So, always check for a 'microwave-safe' label before placing your favourite bowl into the microwave oven.
Also Read: Deliciously Dangerous: Why Microwave Popcorn Can Be Terribly Harmful
Photo Credit: iStock
The Bottom Line
Microwave-safe plastic does not mean it is chemical-free. Sure, plastic is convenient, but that could come at the cost of your long-term health. So, the next time you are about to reheat that leftover biryani in a plastic dabba, hit pause and reach for a glass or ceramic bowl. Then microwave your food like a pro.
Advertisement
About Somdatta Saha Explorer- this is what Somdatta likes to call herself. Be it in terms of food, people or places, all she craves for is to know the unknown. A simple aglio olio pasta or daal-chawal and a good movie can make her day.
For the latest food news, health tips and recipes, like us on Facebook or follow us on Twitter and YouTube.
Tags:
Microwave Safe Containers
Microwave Oven
Plastic Container
Show full article
Comments
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
27 minutes ago
- Hindustan Times
Talent loss a major threat to addressing global AMR crisis
Antimicrobial resistance (AMR) is turning out to be one of the major health calamities, with two million deaths projected to occur in India alone by 2025 and 10 million globally. While the discovery of penicillin in 1928, revolutionised the field of medicine and saved millions of lives, the industry has witnessed a constant decline in the development of new antibiotics ever since then. The lack of resources and high investments are the widely considered reasons for this gap, but one key aspect that remains largely overlooked is the loss of potent scientific and research talent for more than two decades. In an in-depth research report, Leaving the Lab, AMR Industry Alliance highlights alarming data on this brain drain phenomenon. According to the study, research and development (R&D) workforce is limited with approximately 3,000 AMR researchers currently active in the world, compared to around 46,000 for cancer and 5,000 for HIV/AIDS. Meanwhile, the total number of authors on all AMR publications declined from a high of 3,599 in 1995 to just 1,827 in 2020. Investigators with a focused research interest in AMR too have further declined since the mid-1990s, falling from a peak of 1,300 to less than 700 by 2020. The situation is even more worrisome in the context of India. According to the World Health Organization (WHO), India contributes only 1% to the global antibacterial R&D pipeline, whereas 84% of this research is concentrated in high-income countries, with another 12% in upper-middle-income economies. For a country like India which not only carries one of the world's highest burdens of AMR but also contributes meaningfully to AMR resistance on the global level, the lack of focus on research and innovation severely undermines the efforts to combat this threat. The 2016 UNGA High-Level Meeting on AMR discussed a number of actions, including talent loss to address these challenges globally. However, the industry is still witnessing slow progress on work to contain AMR. This brain drain could further exacerbate the situation if necessary steps aren't taken to tackle the crisis at hand. This current trajectory of AMR research is deeply troubling and stems from a fundamental market failure. Currently most of the private investors and governments prefer directing fund to research in other disease areas, creating a vacuum for companies and SMEs who actively want to amplify work in the field of AMR. And even if some of the biggest players in the market invest in creating new antibiotics, they often don't attract investment. In recent years, AstraZeneca, Novartis, and Johnson & Johnson have all exited or cut back their work on AMR, including closing R&D facilities, selling antimicrobial portfolios, ending AMR development, and letting go of research teams. While SMEs are more agile and innovative in early-stage research and development of antibiotics in comparison to the bigger players, their situation too is marred by lack of funding globally. According to a report by the BEAM Alliance, 54% of the SME members struggle with enough funds to cover even a year's worth of operations and fear bankruptcy. Biopharmaceutical company, Achaogen is a prime example. Even after securing US FDA approval for plazomicin, the company was still forced to declare bankruptcy in April 2019 – after spending nearly a billion dollars and over a decade developing the antibiotic. This phenomenon further exacerbates the broken market for antimicrobials where major pharmaceutical companies are unable to offer long-term careers as they either fear bankruptcy or lack of investments and funding to continue research. On the incentives front, clinicians in antimicrobial and antifungal R&D teams face significant pay gaps when compared to fellowships across all other specialties. In 2022, 44% of infectious disease fellowships went unfilled in the US – more than double the proportion of unfilled fellowships across all specialties. A 2022 Medscape report showed a pay gap of $4,000 between infectious disease doctors and internal medicine doctors across the US, despite the additional years of training and debt required. While India has made commendable strides in public health in the recent years, AMR continues to represent an unprecedented challenge--it can't be resolved by treatment alone. As the most populated country across the globe, India needs to have a strong, sustained investment in scientific human capital to challenge the future risks related to AMR. The government has initiated varied efforts in identifying and filling gaps in knowledge on the development of new antibiotics and alternatives to existing one to combat AMR. For instance, department of biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC's) mission to amplify research in the identification of new bacterial targets; call for proposals under the AMR Interdisciplinary Research (AMRIT) Team Grants, to foster collaborative research in AMR and collaboration with UK-based innovation charity organisation, Nesta, to create a pipeline of innovators who can develop a point–of–care diagnostic test to conserve antibiotics for future generations, are some of the progressive steps in fight against AMR. Additionally, ICMR's flagship initiative Antimicrobial Resistance Surveillance & Research Network (AMRSN) to generate high-quality data on AMR trends across India through 30 tertiary care hospitals and research institutions; funding R&D in areas such as rapid diagnostics, novel antimicrobials with international bodies like WHO, CDC (USA), and the Fleming Fund are other examples of India's efforts. Despite these efforts, challenges do persist in providing the much-needed boost in generating a talented workforce of scientists, researchers and innovators to fight against AMR. One of the major systemic challenges facing loss of scientific talent is due to academia–industry leakages. Despite producing highly skilled microbiologists, pharmacologists, and biotechnologists, LMICs like India struggle to retain researchers in the AMR domain due to inadequate funding, limited career pathways and lack of translational research ecosystems. Additionally, limited interest from the industry to invest in providing hands-on training to the emerging talent further amplifies the challenges. To mitigate these challenges, India Pharma Inc. needs to support adequate funding and pull incentives to support the talent eager to work in the field of AMR. The industry and the government must come together to support antimicrobial stewardship programs while ensuring adequate resources, and robust research infrastructure to retain and nurture talent in the larger ecosystem. Government bodies like BIRAC should further intensify their schemes like Biotechnology Ignition Grant (BIG) or Small Business Innovation Research Initiative (SBIRI) to seed innovation and support long-term product development, and market access in AMR. Given the alacrity of challenge at hand, India must focus towards creating a robust pipeline or sustained funding ecosystem for retaining talent instrumental in pushing new breakthrough in antibiotic discovery. Ensuring that we have a workforce of trained research personnel will be crucial for research funding to go as far as possible and yield the most successful results to tackle AMR. This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre.
&w=3840&q=100)
First Post
an hour ago
- First Post
Covid-19 now just like any other respiratory illness, predominant in India after recent surge: Expert
SARS-CoV-2, the virus that causes Covid-19 disease, is just like any other respiratory illness now and there is no possibility of another catastrophic wave like the one driven by Delta variant in 2021, according to Soumya Swaminathan, a former Chief Scientist at the World Health Organization (WHO). read more At present, 'LF.7' and 'NB.1.8' — both descendants of the 'JN.1' variant — are the main variants of the COVID-19-causing virus circulating in Singapore. AP File Soumya Swaminathan, a former Chief Scientist at the World Health Organization (WHO), has said that SARS-CoV-2, the virus that causes Covid-19 disease, is now just like any other respiratory virus and there is no need to panic at the moment. In recent weeks, Covid-19 cases have risen in India. As per the latest information, there are 3,961 active Covid-19 cases in the country, with 203 new cases and four deaths being reported in the previous 24 hours. STORY CONTINUES BELOW THIS AD In an interview with CNN-News 18, Swaminathan said that the SARS-CoV-2, just like any other virus, is bound to periodic surges every six to eight months and the ongoing spike in cases is a result of such a periodic surge. She went on to compare it with influenza virus. 'It has been around now for five years. It is of course constantly mutating and changing like other viruses. And, just like we get every year a spike of influenza cases at certain seasons, we have also now started seeing that periodically, maybe every six to eight months or so, there is a rise in Covid cases,' said Swaminathan, who also served as the Director General of Indian Council of Medical Research (ICMR) during 2015-17. Swaminathan further said that there was no chance of another catastrophic wave of Covid-19 like the Delta variant's wave of 2021. Swaminathan noted that influenza virus was the predominant respiratory infection for most of the year and it was only in April and May that Covid-19 over influenza. She said that it is likely to happen now as Covid-19 has become just another viral infection now. Swaminathan said, 'It's likely that every few months or once a year, we will see this type of thing happening in the future. The good thing is, of course, that we all have immunity now, both from vaccination and from natural infections that many of us have had in the last few years. And, so, what you're seeing now is a mild disease mostly, even though people are testing and reporting positivity, you find that hospitalisations are very few.' STORY CONTINUES BELOW THIS AD While there is no need to panic, people with higher risk of sickness should take the usual precautions, said Swaminathan. Those with higher risk include people with compromised immune systems, pre-existing health conditions, and older people, according to Swaminathan.
Time of India
3 hours ago
- Time of India
Liver Health: Health expert warns about the ‘worst' drink that can damage the liver
Liver diseases claim about 2 million deaths annually, which is about 4% of all deaths worldwide. A vital organ in the body, the is responsible for over 500 functions, including the digestion of proteins, mineral storage, bile production, and blood filtration. Tired of too many ads? go ad free now Keeping the liver in good shape is crucial for overall well-being. Dr. Eric Berg, a chiropractor and nutrition author who has guided hundreds toward better health, has now warned about a beverage that can cause devastating effects on liver health. Most dangerous drink for the liver 'The most dangerous drink for your liver is NOT what you think…' he said in a video shared on Instagram. Sodas and other sugary beverages often have a bad reputation for causing harm to the . However, a drink is far worse than those beverages. 'The worst drink for your liver is not soda with high fructose corn syrup. And it's not even beer or wine. There's something that is way more deadly. Drinking this is the fastest way to destroy your liver,' Dr. Berg said. He said that two shots of this beverage in question can 'rapidly' destroy the liver. The beverage in question is hard liquor. Yes, that's right. He adds that the liver gets overwhelmed when one drinks hard liquor. Now the liver has to break down and digest a toxic byproduct called acetaldehyde, which kills liver cells. This byproduct causes inflammation and overwhelms the liver's ability to regenerate. 'The worst drink for your liver is hard liquor. I'm talking about the high proof alcohol, like 190 proof, 90%,' he said. Why is hard liquor dangerous Alcohol is a toxic, psychoactive, and dependence-producing substance, that can wreak havoc on health. The World Health Organization (WHO) has stressed that no level of alcohol is safe for consumption. Tired of too many ads? go ad free now While all alcoholic beverages can strain the liver, high-proof spirits are particularly harmful due to their concentrated alcohol content. Unlike beer or wine, which typically contain 5-12% alcohol, hard liquors or grain alcohol can reach 90% alcohol by volume. This potency accelerates the production of acetaldehyde, overwhelming the liver's detoxification pathways. Chronic consumption of high-proof alcohol can lead to inflammation and oxidative stress, which impair the liver's ability to repair itself. Over time, this can result in irreversible damage, which may eventually lead to liver failure. Fatty liver diet: Best and worst foods for your liver Dr Carina Ferreira-Borges, acting Unit Lead for Noncommunicable Disease Management and Regional Advisor for Alcohol and Illicit Drugs in the WHO Regional Office for Europe has earlier said, 'We cannot talk about a so-called safe level of alcohol use. It doesn't matter how much you drink – the risk to the drinker's health starts from the first drop of any alcoholic beverage. The only thing that we can say for sure is that the more you drink, the more harmful it is – or, in other words, the less you drink, the safer it is. '
